Idera Pharmaceuticals, Inc.

( )
IDRA PreMarket: $ () as of AM
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Daily Pre-Market Movers
Receive our daily pre-market mover email, free.
100% secure: your email is never shared, and you may opt out at any time.
Health Technology » Biotechnology
MRNAModerna, Inc. 0.32%158.130.0%$4783.41m
NVAXNovavax, Inc. 0.00%129.1692.9%$692.15m
BIIBBiogen, Inc. 0.00%244.091.7%$657.62m
BNTXBioNTech SE -1.85%116.480.0%$644.14m
AMGNAmgen, Inc. 0.00%226.911.3%$592.96m
GILDGilead Sciences, Inc. 0.62%61.241.0%$521.54m
VRTXVertex Pharmaceuticals, Inc. 0.00%226.871.9%$485.44m
REGNRegeneron Pharmaceuticals, Inc. 0.00%498.842.7%$482.97m
ILMNIllumina, Inc. 0.00%346.003.5%$428.45m
EXASEXACT Sciences Corp. 0.00%130.6719.6%$199.30m
APVOAptevo Therapeutics, Inc. 0.00%45.9918.3%$174.42m
SGENSeagen Inc. 0.00%180.165.8%$171.25m
ALXNAlexion Pharmaceuticals, Inc. 0.00%121.062.0%$141.98m
BGNEBeiGene Ltd. 0.00%221.311.4%$135.66m
SRNESorrento Therapeutics, Inc. -0.75%7.911.4%$134.74m

Company Profile

Idera Pharmaceuticals, Inc. is a clinical stage biopharmaceutical company, which focuses on the clinical development, and commercialization of drug candidates for both oncology and rare disease indications. The company was founded by Paul C. Zamecnik, Sudhir A. Agrawal, and James B. Wyngaarden on May 25, 1989 and is headquartered in Cambridge, MA.